FDA expanding access to pancreatic cancer drug to some patients
·1 min read
·
0 reactions
·
0 comments
·
4 views
The FDA this week announced it would be expanding access to a promising pancreatic cancer drug that nearly doubled survival time for patients with advanced pancreatic cancer in a large clinical trial.
Original article
Cbsnews
Anonymous · no account needed